According to Latest Research, the global market for Vascular Embolization Agent should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Vascular Embolization Agent market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Vascular Embolization Agent market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Temporary segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Vascular Embolization Agent include Abbott, Boston Scientific Corporation, Cook Medical LLC, Johnson & Johnson, Medtronic, Acandis GmbH, SSEM Mthembu Medical (Pty) Ltd, Balt USA LLC and Stryker, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Vascular Embolization Agent. Report Highlights:
(1) Global Vascular Embolization Agent market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Vascular Embolization Agent market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Vascular Embolization Agent market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Vascular Embolization Agent segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Vascular Embolization Agent segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Vascular Embolization Agent, capacity, production and trends.
(7) Vascular Embolization Agent industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Temporary
Permanent
Market segment by application, can be divided into
Hospital
Ambulatory Surgery Center
Market segment by players, this report covers
Abbott
Boston Scientific Corporation
Cook Medical LLC
Johnson & Johnson
Medtronic
Acandis GmbH
SSEM Mthembu Medical (Pty) Ltd
Balt USA LLC
Stryker
Guerbet LLC
Terumo Corporation
Penumbra
Grandpharma (Sirtex)
Merit Medical
Siemens Healthineers (Varian)
Jiangsu Hengrui Medicine
Kaneka
Meril Life Sciences
Peijia Medical
Wallaby Medical
MicroPort Scientific Corporation
Weihai Visee Medical Devices
Beijing Taijieweiye Technology
1 Market Overview
1.1 Vascular Embolization Agent Definition
1.2 Global Vascular Embolization Agent Market Size and Forecast
1.2.1 By Revenue, Global Vascular Embolization Agent Market Size, 2018-2029
1.2.2 By Sales Volume, Global Vascular Embolization Agent Market Size, 2018-2029
1.2.3 Global Vascular Embolization Agent Price Trend, 2018-2029
1.3 China Vascular Embolization Agent Market Size and Forecast
1.3.1 By Revenue, China Vascular Embolization Agent Market Size, 2018-2029
1.3.2 By Sales Volume, China Vascular Embolization Agent Market Size, 2018-2029
1.3.3 China Vascular Embolization Agent Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Vascular Embolization Agent Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Vascular Embolization Agent Share in Global Market, 2018-2029
1.4.3 Vascular Embolization Agent Market Size: China VS Global, 2018-2029
1.5 Vascular Embolization Agent Market Dynamics
1.5.1 Vascular Embolization Agent Market Drivers
1.5.2 Vascular Embolization Agent Market Restraints
1.5.3 Vascular Embolization Agent Industry Trends
1.5.4 Vascular Embolization Agent Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Vascular Embolization Agent Revenue by Company, 2018-2023
2.2 Global Vascular Embolization Agent Sales Volume by Company, 2018-2023
2.3 Global Vascular Embolization Agent Price by Company, 2018-2023
2.4 Global Vascular Embolization Agent Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Vascular Embolization Agent Concentration Ratio
2.6 Global Vascular Embolization Agent Mergers & Acquisitions, Expansion Plans
2.7 Global Vascular Embolization Agent Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Vascular Embolization Agent Revenue by Company, 2018-2023
3.2 China Vascular Embolization Agent Sales Volume by Company, 2018-2023
3.3 China Vascular Embolization Agent Vascular Embolization Agent Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Vascular Embolization Agent Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Vascular Embolization Agent Domestic VS Export
3.6 China Market, Vascular Embolization Agent Import & Export
3.6.1 China Market, Vascular Embolization Agent Import & Export, 2018-2029
3.6.2 China Vascular Embolization Agent Import & Export Trends
3.6.3 Main Sources of China Vascular Embolization Agent Import
3.6.4 Export Destination of China Vascular Embolization Agent
4 Vascular Embolization Agent Production by Region
4.1 Global Vascular Embolization Agent Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Vascular Embolization Agent Manufacturers
4.3 Global Major Manufacturers, Vascular Embolization Agent Capacity Expansion and Future Plans
4.4 Global Vascular Embolization Agent Capacity by Region
4.5 Global Vascular Embolization Agent Production by Region
4.5.1 Global Vascular Embolization Agent Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Vascular Embolization Agent Production by Region, 2018-2023
4.5.3 Global Vascular Embolization Agent Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Vascular Embolization Agent Industry Chain
5.2 Vascular Embolization Agent Upstream Analysis
5.2.1 Vascular Embolization Agent Core Raw Materials
5.2.2 Main Manufacturers of Vascular Embolization Agent Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Vascular Embolization Agent Production Mode
5.6 Vascular Embolization Agent Procurement Model
5.7 Vascular Embolization Agent Industry Sales Model and Sales Channels
5.7.1 Vascular Embolization Agent Sales Model
5.7.2 Vascular Embolization Agent Typical Distributors
6 Sights by Type
6.1 Vascular Embolization Agent Classification
6.1.1 Temporary
6.1.2 Permanent
6.2 By Type, Global Vascular Embolization Agent Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Vascular Embolization Agent Revenue, 2018-2029
6.4 By Type, Global Vascular Embolization Agent Sales Volume, 2018-2029
6.5 By Type, Global Vascular Embolization Agent Price, 2018-2029
7 Sights by Application
7.1 Vascular Embolization Agent Segment by Application
7.1.1 Hospital
7.1.2 Ambulatory Surgery Center
7.2 By Application, Global Vascular Embolization Agent Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Vascular Embolization Agent Revenue, 2018-2029
7.4 By Application, Global Vascular Embolization Agent Sales Volume, 2018-2029
7.5 By Application, Global Vascular Embolization Agent Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Vascular Embolization Agent Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Vascular Embolization Agent Revenue, 2018-2029
8.3 By Region, Global Vascular Embolization Agent Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Vascular Embolization Agent Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Vascular Embolization Agent Market Size Market Share
8.5 Europe
8.5.1 Europe Vascular Embolization Agent Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Vascular Embolization Agent Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Vascular Embolization Agent Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Vascular Embolization Agent Market Size Market Share
8.7 South America
8.7.1 South America Vascular Embolization Agent Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Vascular Embolization Agent Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Vascular Embolization Agent Market Size & CAGR,2018 VS 2022 VS 2029
9.2 By Country, Global Vascular Embolization Agent Revenue, 2018-2029
9.3 By Country, Global Vascular Embolization Agent Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Vascular Embolization Agent Market Size, 2018-2029
9.4.2 By Company, U.S. Vascular Embolization Agent Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Vascular Embolization Agent Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Vascular Embolization Agent Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Vascular Embolization Agent Market Size, 2018-2029
9.5.2 By Company, Europe Vascular Embolization Agent Sales Volume Market Share, 2022
9.5.3 By Type, Europe Vascular Embolization Agent Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Vascular Embolization Agent Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Vascular Embolization Agent Market Size, 2018-2029
9.6.2 By Company, China Vascular Embolization Agent Sales Volume Market Share, 2022
9.6.3 By Type, China Vascular Embolization Agent Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Vascular Embolization Agent Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Vascular Embolization Agent Market Size, 2018-2029
9.7.2 By Company, Japan Vascular Embolization Agent Sales Volume Market Share, 2022
9.7.3 By Type, Japan Vascular Embolization Agent Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Vascular Embolization Agent Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Vascular Embolization Agent Market Size, 2018-2029
9.8.2 By Company, South Korea Vascular Embolization Agent Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Vascular Embolization Agent Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Vascular Embolization Agent Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Vascular Embolization Agent Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Vascular Embolization Agent Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Vascular Embolization Agent Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Vascular Embolization Agent Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Vascular Embolization Agent Market Size, 2018-2029
9.10.2 By Company, India Vascular Embolization Agent Sales Volume Market Share, 2022
9.10.3 By Type, India Vascular Embolization Agent Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Vascular Embolization Agent Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Vascular Embolization Agent Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Vascular Embolization Agent Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Vascular Embolization Agent Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Vascular Embolization Agent Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Abbott
10.1.1 Abbott Company Information, Head Office, Market Area and Industry Position
10.1.2 Abbott Vascular Embolization Agent Models, Specifications and Application
10.1.3 Abbott Vascular Embolization Agent Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Abbott Company Profile and Main Business
10.1.5 Abbott Recent Developments
10.2 Boston Scientific Corporation
10.2.1 Boston Scientific Corporation Company Information, Head Office, Market Area and Industry Position
10.2.2 Boston Scientific Corporation Vascular Embolization Agent Models, Specifications and Application
10.2.3 Boston Scientific Corporation Vascular Embolization Agent Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Boston Scientific Corporation Company Profile and Main Business
10.2.5 Boston Scientific Corporation Recent Developments
10.3 Cook Medical LLC
10.3.1 Cook Medical LLC Company Information, Head Office, Market Area and Industry Position
10.3.2 Cook Medical LLC Vascular Embolization Agent Models, Specifications and Application
10.3.3 Cook Medical LLC Vascular Embolization Agent Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Cook Medical LLC Company Profile and Main Business
10.3.5 Cook Medical LLC Recent Developments
10.4 Johnson & Johnson
10.4.1 Johnson & Johnson Company Information, Head Office, Market Area and Industry Position
10.4.2 Johnson & Johnson Vascular Embolization Agent Models, Specifications and Application
10.4.3 Johnson & Johnson Vascular Embolization Agent Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Johnson & Johnson Company Profile and Main Business
10.4.5 Johnson & Johnson Recent Developments
10.5 Medtronic
10.5.1 Medtronic Company Information, Head Office, Market Area and Industry Position
10.5.2 Medtronic Vascular Embolization Agent Models, Specifications and Application
10.5.3 Medtronic Vascular Embolization Agent Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Medtronic Company Profile and Main Business
10.5.5 Medtronic Recent Developments
10.6 Acandis GmbH
10.6.1 Acandis GmbH Company Information, Head Office, Market Area and Industry Position
10.6.2 Acandis GmbH Vascular Embolization Agent Models, Specifications and Application
10.6.3 Acandis GmbH Vascular Embolization Agent Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Acandis GmbH Company Profile and Main Business
10.6.5 Acandis GmbH Recent Developments
10.7 SSEM Mthembu Medical (Pty) Ltd
10.7.1 SSEM Mthembu Medical (Pty) Ltd Company Information, Head Office, Market Area and Industry Position
10.7.2 SSEM Mthembu Medical (Pty) Ltd Vascular Embolization Agent Models, Specifications and Application
10.7.3 SSEM Mthembu Medical (Pty) Ltd Vascular Embolization Agent Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 SSEM Mthembu Medical (Pty) Ltd Company Profile and Main Business
10.7.5 SSEM Mthembu Medical (Pty) Ltd Recent Developments
10.8 Balt USA LLC
10.8.1 Balt USA LLC Company Information, Head Office, Market Area and Industry Position
10.8.2 Balt USA LLC Vascular Embolization Agent Models, Specifications and Application
10.8.3 Balt USA LLC Vascular Embolization Agent Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Balt USA LLC Company Profile and Main Business
10.8.5 Balt USA LLC Recent Developments
10.9 Stryker
10.9.1 Stryker Company Information, Head Office, Market Area and Industry Position
10.9.2 Stryker Vascular Embolization Agent Models, Specifications and Application
10.9.3 Stryker Vascular Embolization Agent Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Stryker Company Profile and Main Business
10.9.5 Stryker Recent Developments
10.10 Guerbet LLC
10.10.1 Guerbet LLC Company Information, Head Office, Market Area and Industry Position
10.10.2 Guerbet LLC Vascular Embolization Agent Models, Specifications and Application
10.10.3 Guerbet LLC Vascular Embolization Agent Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Guerbet LLC Company Profile and Main Business
10.10.5 Guerbet LLC Recent Developments
10.11 Terumo Corporation
10.11.1 Terumo Corporation Company Information, Head Office, Market Area and Industry Position
10.11.2 Terumo Corporation Vascular Embolization Agent Models, Specifications and Application
10.11.3 Terumo Corporation Vascular Embolization Agent Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Terumo Corporation Company Profile and Main Business
10.11.5 Terumo Corporation Recent Developments
10.12 Penumbra
10.12.1 Penumbra Company Information, Head Office, Market Area and Industry Position
10.12.2 Penumbra Vascular Embolization Agent Models, Specifications and Application
10.12.3 Penumbra Vascular Embolization Agent Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Penumbra Company Profile and Main Business
10.12.5 Penumbra Recent Developments
10.13 Grandpharma (Sirtex)
10.13.1 Grandpharma (Sirtex) Company Information, Head Office, Market Area and Industry Position
10.13.2 Grandpharma (Sirtex) Vascular Embolization Agent Models, Specifications and Application
10.13.3 Grandpharma (Sirtex) Vascular Embolization Agent Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Grandpharma (Sirtex) Company Profile and Main Business
10.13.5 Grandpharma (Sirtex) Recent Developments
10.14 Merit Medical
10.14.1 Merit Medical Company Information, Head Office, Market Area and Industry Position
10.14.2 Merit Medical Vascular Embolization Agent Models, Specifications and Application
10.14.3 Merit Medical Vascular Embolization Agent Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Merit Medical Company Profile and Main Business
10.14.5 Merit Medical Recent Developments
10.15 Siemens Healthineers (Varian)
10.15.1 Siemens Healthineers (Varian) Company Information, Head Office, Market Area and Industry Position
10.15.2 Siemens Healthineers (Varian) Vascular Embolization Agent Models, Specifications and Application
10.15.3 Siemens Healthineers (Varian) Vascular Embolization Agent Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Siemens Healthineers (Varian) Company Profile and Main Business
10.15.5 Siemens Healthineers (Varian) Recent Developments
10.16 Jiangsu Hengrui Medicine
10.16.1 Jiangsu Hengrui Medicine Company Information, Head Office, Market Area and Industry Position
10.16.2 Jiangsu Hengrui Medicine Vascular Embolization Agent Models, Specifications and Application
10.16.3 Jiangsu Hengrui Medicine Vascular Embolization Agent Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.16.4 Jiangsu Hengrui Medicine Company Profile and Main Business
10.16.5 Jiangsu Hengrui Medicine Recent Developments
10.17 Kaneka
10.17.1 Kaneka Company Information, Head Office, Market Area and Industry Position
10.17.2 Kaneka Vascular Embolization Agent Models, Specifications and Application
10.17.3 Kaneka Vascular Embolization Agent Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.17.4 Kaneka Company Profile and Main Business
10.17.5 Kaneka Recent Developments
10.18 Meril Life Sciences
10.18.1 Meril Life Sciences Company Information, Head Office, Market Area and Industry Position
10.18.2 Meril Life Sciences Vascular Embolization Agent Models, Specifications and Application
10.18.3 Meril Life Sciences Vascular Embolization Agent Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.18.4 Meril Life Sciences Company Profile and Main Business
10.18.5 Meril Life Sciences Recent Developments
10.19 Peijia Medical
10.19.1 Peijia Medical Company Information, Head Office, Market Area and Industry Position
10.19.2 Peijia Medical Vascular Embolization Agent Models, Specifications and Application
10.19.3 Peijia Medical Vascular Embolization Agent Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.19.4 Peijia Medical Company Profile and Main Business
10.19.5 Peijia Medical Recent Developments
10.20 Wallaby Medical
10.20.1 Wallaby Medical Company Information, Head Office, Market Area and Industry Position
10.20.2 Wallaby Medical Vascular Embolization Agent Models, Specifications and Application
10.20.3 Wallaby Medical Vascular Embolization Agent Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.20.4 Wallaby Medical Company Profile and Main Business
10.20.5 Wallaby Medical Recent Developments
10.21 MicroPort Scientific Corporation
10.21.1 MicroPort Scientific Corporation Company Information, Head Office, Market Area and Industry Position
10.21.2 MicroPort Scientific Corporation Vascular Embolization Agent Models, Specifications and Application
10.21.3 MicroPort Scientific Corporation Vascular Embolization Agent Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.21.4 MicroPort Scientific Corporation Company Profile and Main Business
10.21.5 MicroPort Scientific Corporation Recent Developments
10.22 Weihai Visee Medical Devices
10.22.1 Weihai Visee Medical Devices Company Information, Head Office, Market Area and Industry Position
10.22.2 Weihai Visee Medical Devices Vascular Embolization Agent Models, Specifications and Application
10.22.3 Weihai Visee Medical Devices Vascular Embolization Agent Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.22.4 Weihai Visee Medical Devices Company Profile and Main Business
10.22.5 Weihai Visee Medical Devices Recent Developments
10.23 Beijing Taijieweiye Technology
10.23.1 Beijing Taijieweiye Technology Company Information, Head Office, Market Area and Industry Position
10.23.2 Beijing Taijieweiye Technology Vascular Embolization Agent Models, Specifications and Application
10.23.3 Beijing Taijieweiye Technology Vascular Embolization Agent Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.23.4 Beijing Taijieweiye Technology Company Profile and Main Business
10.23.5 Beijing Taijieweiye Technology Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Vascular Embolization Agent Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Vascular Embolization Agent Market Restraints
Table 3. Vascular Embolization Agent Market Trends
Table 4. Vascular Embolization Agent Industry Policy
Table 5. Global Vascular Embolization Agent Revenue by Company, 2018-2023, US$ million
Table 6. Global Vascular Embolization Agent Revenue Market Share by Company, 2018-2023
Table 7. Global Vascular Embolization Agent Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Vascular Embolization Agent Sales Volume Market Share by Company, 2018-2023
Table 9. Global Vascular Embolization Agent Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Vascular Embolization Agent Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Vascular Embolization Agent Mergers & Acquisitions, Expansion Plans
Table 12. Global Vascular Embolization Agent Manufacturers Product Type
Table 13. China Vascular Embolization Agent Revenue by Company, 2018-2023, US$ million
Table 14. China Vascular Embolization Agent Revenue Market Share by Company, 2018-2023
Table 15. China Vascular Embolization Agent Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Vascular Embolization Agent Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Vascular Embolization Agent Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Vascular Embolization Agent Import & Export Trends
Table 19. Main Sources of China Vascular Embolization Agent Import
Table 20. Export Destination of China Vascular Embolization Agent
Table 21. Global Headquarters and Manufacturing Base of Vascular Embolization Agent Manufacturers
Table 22. Global Major Manufacturers, Vascular Embolization Agent Capacity Expansion and Future Plans
Table 23. Global Vascular Embolization Agent Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Vascular Embolization Agent Production by Region, 2018-2023, (K Units)
Table 25. Global Vascular Embolization Agent Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Vascular Embolization Agent Upstream (Raw Materials)
Table 27. Global Vascular Embolization Agent Typical Customers
Table 28. Vascular Embolization Agent Typical Distributors
Table 29. By Type, Global Vascular Embolization Agent Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Vascular Embolization Agent Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Vascular Embolization Agent Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Vascular Embolization Agent Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Vascular Embolization Agent Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Vascular Embolization Agent Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Vascular Embolization Agent Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Vascular Embolization Agent Revenue Market Share, 2018-2029
Table 37. By Country, Global Vascular Embolization Agent Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Vascular Embolization Agent Sales Volume Market Share, 2018-2029
Table 39. Abbott Company Information, Head Office, Market Area and Industry Position
Table 40. Abbott Vascular Embolization Agent Models, Specifications and Application
Table 41. Abbott Vascular Embolization Agent Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Abbott Company Profile and Main Business
Table 43. Abbott Recent Developments
Table 44. Boston Scientific Corporation Company Information, Head Office, Market Area and Industry Position
Table 45. Boston Scientific Corporation Vascular Embolization Agent Models, Specifications and Application
Table 46. Boston Scientific Corporation Vascular Embolization Agent Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Boston Scientific Corporation Company Profile and Main Business
Table 48. Boston Scientific Corporation Recent Developments
Table 49. Cook Medical LLC Company Information, Head Office, Market Area and Industry Position
Table 50. Cook Medical LLC Vascular Embolization Agent Models, Specifications and Application
Table 51. Cook Medical LLC Vascular Embolization Agent Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Cook Medical LLC Company Profile and Main Business
Table 53. Cook Medical LLC Recent Developments
Table 54. Johnson & Johnson Company Information, Head Office, Market Area and Industry Position
Table 55. Johnson & Johnson Vascular Embolization Agent Models, Specifications and Application
Table 56. Johnson & Johnson Vascular Embolization Agent Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Johnson & Johnson Company Profile and Main Business
Table 58. Johnson & Johnson Recent Developments
Table 59. Medtronic Company Information, Head Office, Market Area and Industry Position
Table 60. Medtronic Vascular Embolization Agent Models, Specifications and Application
Table 61. Medtronic Vascular Embolization Agent Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Medtronic Company Profile and Main Business
Table 63. Medtronic Recent Developments
Table 64. Acandis GmbH Company Information, Head Office, Market Area and Industry Position
Table 65. Acandis GmbH Vascular Embolization Agent Models, Specifications and Application
Table 66. Acandis GmbH Vascular Embolization Agent Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Acandis GmbH Company Profile and Main Business
Table 68. Acandis GmbH Recent Developments
Table 69. SSEM Mthembu Medical (Pty) Ltd Company Information, Head Office, Market Area and Industry Position
Table 70. SSEM Mthembu Medical (Pty) Ltd Vascular Embolization Agent Models, Specifications and Application
Table 71. SSEM Mthembu Medical (Pty) Ltd Vascular Embolization Agent Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. SSEM Mthembu Medical (Pty) Ltd Company Profile and Main Business
Table 73. SSEM Mthembu Medical (Pty) Ltd Recent Developments
Table 74. Balt USA LLC Company Information, Head Office, Market Area and Industry Position
Table 75. Balt USA LLC Vascular Embolization Agent Models, Specifications and Application
Table 76. Balt USA LLC Vascular Embolization Agent Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Balt USA LLC Company Profile and Main Business
Table 78. Balt USA LLC Recent Developments
Table 79. Stryker Company Information, Head Office, Market Area and Industry Position
Table 80. Stryker Vascular Embolization Agent Models, Specifications and Application
Table 81. Stryker Vascular Embolization Agent Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Stryker Company Profile and Main Business
Table 83. Stryker Recent Developments
Table 84. Guerbet LLC Company Information, Head Office, Market Area and Industry Position
Table 85. Guerbet LLC Vascular Embolization Agent Models, Specifications and Application
Table 86. Guerbet LLC Vascular Embolization Agent Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Guerbet LLC Company Profile and Main Business
Table 88. Guerbet LLC Recent Developments
Table 89. Terumo Corporation Company Information, Head Office, Market Area and Industry Position
Table 90. Terumo Corporation Vascular Embolization Agent Models, Specifications and Application
Table 91. Terumo Corporation Vascular Embolization Agent Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Terumo Corporation Company Profile and Main Business
Table 93. Terumo Corporation Recent Developments
Table 94. Penumbra Company Information, Head Office, Market Area and Industry Position
Table 95. Penumbra Vascular Embolization Agent Models, Specifications and Application
Table 96. Penumbra Vascular Embolization Agent Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Penumbra Company Profile and Main Business
Table 98. Penumbra Recent Developments
Table 99. Grandpharma (Sirtex) Company Information, Head Office, Market Area and Industry Position
Table 100. Grandpharma (Sirtex) Vascular Embolization Agent Models, Specifications and Application
Table 101. Grandpharma (Sirtex) Vascular Embolization Agent Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Grandpharma (Sirtex) Company Profile and Main Business
Table 103. Grandpharma (Sirtex) Recent Developments
Table 104. Merit Medical Company Information, Head Office, Market Area and Industry Position
Table 105. Merit Medical Vascular Embolization Agent Models, Specifications and Application
Table 106. Merit Medical Vascular Embolization Agent Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Merit Medical Company Profile and Main Business
Table 108. Merit Medical Recent Developments
Table 109. Siemens Healthineers (Varian) Company Information, Head Office, Market Area and Industry Position
Table 110. Siemens Healthineers (Varian) Vascular Embolization Agent Models, Specifications and Application
Table 111. Siemens Healthineers (Varian) Vascular Embolization Agent Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Siemens Healthineers (Varian) Company Profile and Main Business
Table 113. Siemens Healthineers (Varian) Recent Developments
Table 114. Jiangsu Hengrui Medicine Company Information, Head Office, Market Area and Industry Position
Table 115. Jiangsu Hengrui Medicine Vascular Embolization Agent Models, Specifications and Application
Table 116. Jiangsu Hengrui Medicine Vascular Embolization Agent Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 117. Jiangsu Hengrui Medicine Company Profile and Main Business
Table 118. Jiangsu Hengrui Medicine Recent Developments
Table 119. Kaneka Company Information, Head Office, Market Area and Industry Position
Table 120. Kaneka Vascular Embolization Agent Models, Specifications and Application
Table 121. Kaneka Vascular Embolization Agent Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 122. Kaneka Company Profile and Main Business
Table 123. Kaneka Recent Developments
Table 124. Meril Life Sciences Company Information, Head Office, Market Area and Industry Position
Table 125. Meril Life Sciences Vascular Embolization Agent Models, Specifications and Application
Table 126. Meril Life Sciences Vascular Embolization Agent Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 127. Meril Life Sciences Company Profile and Main Business
Table 128. Meril Lif
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|